Cargando…
Recent Advances in EPAC-Targeted Therapies: A Biophysical Perspective
The universal second messenger cAMP regulates diverse intracellular processes by interacting with ubiquitously expressed proteins, such as Protein Kinase A (PKA) and the Exchange Protein directly Activated by cAMP (EPAC). EPAC is implicated in multiple pathologies, thus several EPAC-specific inhibit...
Autores principales: | Ahmed, Alveena, Boulton, Stephen, Shao, Hongzhao, Akimoto, Madoka, Natarajan, Amarnath, Cheng, Xiaodong, Melacini, Giuseppe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912387/ https://www.ncbi.nlm.nih.gov/pubmed/31752286 http://dx.doi.org/10.3390/cells8111462 |
Ejemplares similares
-
QSAR models reveal new EPAC-selective allosteric modulators
por: Mohamed, Hebatallah, et al.
Publicado: (2022) -
Biochemical and Pharmacological Characterizations of ESI-09 Based EPAC Inhibitors: Defining the ESI-09 “Therapeutic Window”
por: Zhu, Yingmin, et al.
Publicado: (2015) -
A Tool Set to Map Allosteric Networks through the NMR Chemical Shift Covariance Analysis
por: Boulton, Stephen, et al.
Publicado: (2014) -
The Auto-Inhibitory Role of the EPAC Hinge Helix as Mapped by NMR
por: Selvaratnam, Rajeevan, et al.
Publicado: (2012) -
Structure–Activity Relationship Studies with
Tetrahydroquinoline Analogs as EPAC Inhibitors
por: Sonawane, Yogesh A., et al.
Publicado: (2017)